Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2009

01-12-2009 | Review Article

Sir Frank Macfarlane Burnet and the clonal selection theory of antibody formation

Author: Domenico Ribatti

Published in: Clinical and Experimental Medicine | Issue 4/2009

Login to get access

Abstract

Sir Macfarlane Burnet has been one of the twentieth century’s outstanding biologists. In the years 1941–1956, Burnet focused his effort on the elaboration of a theory of antibody synthesis, the clonal selection theory, capable of bridging the gap between physiological findings, such as the kinetics of antibody production, self-tolerance and immunological memory on the one hand, and the newest ideas on synthesis of proteins, on the other. At the time of writing the clonal selection theory, Burnet was 57 years old and the Director of the Water and Eliza Hall Institute in Melbourne, Australia.
Literature
1.
go back to reference Lederberg J (1988) Ontogeny of the clonal selection theory of antibody formation. Reflections on Darwin and Ehrlich. Ann N Y Acad Sci 546:175–187PubMedCrossRef Lederberg J (1988) Ontogeny of the clonal selection theory of antibody formation. Reflections on Darwin and Ehrlich. Ann N Y Acad Sci 546:175–187PubMedCrossRef
2.
go back to reference Forsdyke DR (1995) The origins of the clonal selection theory of immunity as a case study for evaluation in science. FASEB J 9:164–166PubMed Forsdyke DR (1995) The origins of the clonal selection theory of immunity as a case study for evaluation in science. FASEB J 9:164–166PubMed
3.
go back to reference Silverstein AM (2002) The clonal selection theory: what it really is and why modern challenges are misplaced. Nat Immunol 3:793–796PubMedCrossRef Silverstein AM (2002) The clonal selection theory: what it really is and why modern challenges are misplaced. Nat Immunol 3:793–796PubMedCrossRef
4.
go back to reference Editorial (2007) Sir Frank Macfarlane Burnet, 1899–1985. Nat Immunol 8:1009CrossRef Editorial (2007) Sir Frank Macfarlane Burnet, 1899–1985. Nat Immunol 8:1009CrossRef
6.
go back to reference Hodgkin PD, Heath WR, Baxter AG (2007) The clonal selection theory: 50 years since the revolution. Nat Immunol 8:1019–1023PubMedCrossRef Hodgkin PD, Heath WR, Baxter AG (2007) The clonal selection theory: 50 years since the revolution. Nat Immunol 8:1019–1023PubMedCrossRef
7.
go back to reference Cohn M, Mitchison NA, Paul WE et al (2007) Reflections on the clonal-selection theory. Nat Immunol 7:823–830CrossRef Cohn M, Mitchison NA, Paul WE et al (2007) Reflections on the clonal-selection theory. Nat Immunol 7:823–830CrossRef
8.
go back to reference Ada G (2008) The enunciation and impact of Macfarlane Burnet’s clonal selection theory of acquired immunity. Immunol Cell Biol 86:116–118PubMedCrossRef Ada G (2008) The enunciation and impact of Macfarlane Burnet’s clonal selection theory of acquired immunity. Immunol Cell Biol 86:116–118PubMedCrossRef
9.
go back to reference Ribatti D (2006) The fundamental contribution of Robert A. Good to the discovery of the crucial role of thymus in mammalian immunity. Immunology 119:291–295PubMedCrossRef Ribatti D (2006) The fundamental contribution of Robert A. Good to the discovery of the crucial role of thymus in mammalian immunity. Immunology 119:291–295PubMedCrossRef
10.
go back to reference Ribatti D, Crivellato E, Vacca A (2006) Miller’s seminal studies on the role of thymus in immunity. Clin Exp Immunol 144:371–375PubMedCrossRef Ribatti D, Crivellato E, Vacca A (2006) Miller’s seminal studies on the role of thymus in immunity. Clin Exp Immunol 144:371–375PubMedCrossRef
11.
go back to reference Ribatti D, Crivellato E, Vacca A (2006) The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage. Clin Exp Immunol 145:1–4PubMedCrossRef Ribatti D, Crivellato E, Vacca A (2006) The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage. Clin Exp Immunol 145:1–4PubMedCrossRef
12.
go back to reference Breinl F, Haurowitz F (1930) Chemische Untersuchung des Prazipitates aus Hamoglobin and Anti-Hamoglobin-Serum and Bemerkungen ber die Natur der Antikorper. Z Phyisiol Chem 192:45–55 Breinl F, Haurowitz F (1930) Chemische Untersuchung des Prazipitates aus Hamoglobin and Anti-Hamoglobin-Serum and Bemerkungen ber die Natur der Antikorper. Z Phyisiol Chem 192:45–55
13.
go back to reference Mudd S (1932) A hypothetical mechanism of antibody formation. J Immunol 23:423–434 Mudd S (1932) A hypothetical mechanism of antibody formation. J Immunol 23:423–434
14.
go back to reference Pauling L (1940) A theory of the structure and process of formation of antibodies. J Am Chem Soc 62:2643–2657CrossRef Pauling L (1940) A theory of the structure and process of formation of antibodies. J Am Chem Soc 62:2643–2657CrossRef
15.
go back to reference Burnet FM, Freeman M, Jackson AV, Lush D (1941) The production of antibodies: a review and theoretical discussion. Monograph of the Walter and Eliza Hall Institute of Research in Pathology and Medicine, No 1. Macmillan, Melbourne Burnet FM, Freeman M, Jackson AV, Lush D (1941) The production of antibodies: a review and theoretical discussion. Monograph of the Walter and Eliza Hall Institute of Research in Pathology and Medicine, No 1. Macmillan, Melbourne
16.
go back to reference Burnet FM, Fenner F (1949) The production of antibodies, 2nd edn. Monograph of the Walter and Eliza Hall Institute, Macmillan, Melbourne Burnet FM, Fenner F (1949) The production of antibodies, 2nd edn. Monograph of the Walter and Eliza Hall Institute, Macmillan, Melbourne
17.
go back to reference Burnet FM (1953) Natural history of infectious diseases. Cambridge University Press, Cambridge Burnet FM (1953) Natural history of infectious diseases. Cambridge University Press, Cambridge
18.
go back to reference Burnet FM (1956) Enzyme, antigen and virus. Cambridge University Press, Cambridge Burnet FM (1956) Enzyme, antigen and virus. Cambridge University Press, Cambridge
19.
go back to reference Ehrlich P (1900) On the immunity with special reference to cell life. Proc R Soc Lond 66:424–448 Ehrlich P (1900) On the immunity with special reference to cell life. Proc R Soc Lond 66:424–448
20.
go back to reference Jerne NK (1955) The natural selection theory of antibody formation. Proc Natl Acad Sci USA 41:849–857PubMedCrossRef Jerne NK (1955) The natural selection theory of antibody formation. Proc Natl Acad Sci USA 41:849–857PubMedCrossRef
22.
go back to reference Burnet FM (1957) A modification of Jerne’s theory of antibody production using the concept of clonal selection. Aust J Sci 20:67–69 Burnet FM (1957) A modification of Jerne’s theory of antibody production using the concept of clonal selection. Aust J Sci 20:67–69
23.
go back to reference Burnet FM (1959) The clonal selection theory of acquired immunity. Cambridge University Press, Cambridge Burnet FM (1959) The clonal selection theory of acquired immunity. Cambridge University Press, Cambridge
24.
go back to reference Talmage DH (1959) Immunological specificity: unique combinations of selected natural globulins provide an alternative to the classical concept. Science 129:1643–1648PubMedCrossRef Talmage DH (1959) Immunological specificity: unique combinations of selected natural globulins provide an alternative to the classical concept. Science 129:1643–1648PubMedCrossRef
25.
26.
go back to reference Nossal GJV (1960) Ph.D. thesis. University of Sidney, Sidney Nossal GJV (1960) Ph.D. thesis. University of Sidney, Sidney
28.
go back to reference Attardi G, Cohn M, Horibata K, Lennox ES (1958) On the analysis of antibody synthesis at cellular level. Bacteriol Rev 23:213–223 Attardi G, Cohn M, Horibata K, Lennox ES (1958) On the analysis of antibody synthesis at cellular level. Bacteriol Rev 23:213–223
29.
go back to reference Jerne NK, Nordin AA (1963) Plaque formation in agar by single antibody-producing cells. Science 140:405CrossRef Jerne NK, Nordin AA (1963) Plaque formation in agar by single antibody-producing cells. Science 140:405CrossRef
30.
go back to reference Palyfair JHL, Papermaster BW, Cole LJ (1965) Focal antibody production by transferred spleen cells in irradiated mice. Science 149:998–1000CrossRef Palyfair JHL, Papermaster BW, Cole LJ (1965) Focal antibody production by transferred spleen cells in irradiated mice. Science 149:998–1000CrossRef
31.
go back to reference Raff MC, Feldman M, de Petris S (1973) Monospecificity of bone marrow derived lymphocytes. J Exp Med 137:1024–1030PubMedCrossRef Raff MC, Feldman M, de Petris S (1973) Monospecificity of bone marrow derived lymphocytes. J Exp Med 137:1024–1030PubMedCrossRef
32.
go back to reference Kohler G, Milstein C (1975) Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511–519CrossRef Kohler G, Milstein C (1975) Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511–519CrossRef
33.
go back to reference Burnet FM (1967) The impact on ideas of immunology. Cold Spring Harb Symp Quant Biol 32:1–8 Burnet FM (1967) The impact on ideas of immunology. Cold Spring Harb Symp Quant Biol 32:1–8
34.
go back to reference Jerne NK (1967) Waiting for the end: a summary. Cold Spring Harb Symp Quant Biol 32:591 Jerne NK (1967) Waiting for the end: a summary. Cold Spring Harb Symp Quant Biol 32:591
Metadata
Title
Sir Frank Macfarlane Burnet and the clonal selection theory of antibody formation
Author
Domenico Ribatti
Publication date
01-12-2009
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 4/2009
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-009-0048-y

Other articles of this Issue 4/2009

Clinical and Experimental Medicine 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.